(Q44592181)

4 December 2017

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response (English)

1 reference

4 December 2017

0 references

1

1 reference

4 December 2017

2

1 reference

4 December 2017

3

Jeffrey A Lieberman

1 reference

4 December 2017

4

0 references

James L. Kennedy

series ordinal

6

object named as

James L Kennedy

1 reference

PubMed ID

18500637

4 December 2017

Albert Hung Choy Wong

series ordinal

5

object named as

Albert H C Wong

1 reference

4 December 2017

26 May 2008

1 reference

4 December 2017

1 reference

4 December 2017

200

1 reference

4 December 2017

2

1 reference

4 December 2017

177-186

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-008-1193-9

4 December 2017

0 references

cites work

Other method for adjustment of multiple testing exists

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Multiple test procedures other than Bonferroni's deserve wider use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Phosphorylation of glycogen synthase kinase-3beta at serine-9 by phospholipase Cgamma1 through protein kinase C in rat 3Y1 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1193-9

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

21 January 2018

1 reference

12 December 2020

A note on exact tests of Hardy-Weinberg equilibrium

1 reference

12 December 2020

ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies

1 reference

12 December 2020

Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder

1 reference

12 December 2020

Rational inferences about departures from Hardy-Weinberg equilibrium

1 reference

12 December 2020

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

1 reference

12 December 2020

Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus

1 reference

12 December 2020

PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data

1 reference

12 December 2020

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

1 reference

12 December 2020

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

12 December 2020

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.

1 reference

12 December 2020

The effects of clozapine on the GSK-3-mediated signaling pathway

1 reference

12 December 2020

Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex

1 reference

12 December 2020

Low GSK-3 activity in frontal cortex of schizophrenic patients.

1 reference

12 December 2020

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

1 reference

12 December 2020

Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.

1 reference

12 December 2020

The structure of haplotype blocks in the human genome

1 reference

12 December 2020

The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats

1 reference

12 December 2020

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

1 reference

12 December 2020

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.

1 reference

12 December 2020

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

1 reference

12 December 2020

Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia.

1 reference

12 December 2020

Haploview: analysis and visualization of LD and haplotype maps

1 reference

12 December 2020

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

1 reference

12 December 2020

Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality.

1 reference

12 December 2020

Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum

1 reference

12 December 2020

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study

1 reference

12 December 2020

Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia

1 reference

12 December 2020

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

1 reference

12 December 2020

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

12 December 2020

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

1 reference

12 December 2020

Side effects of atypical antipsychotic drugs

1 reference

12 December 2020

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

1 reference

12 December 2020

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

1 reference

12 December 2020

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

1 reference

12 December 2020

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain

1 reference

12 December 2020

Adverse effects of antipsychotic drugs

1 reference

12 December 2020

Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia

1 reference

12 December 2020

Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.

1 reference

12 December 2020

The glamour and gloom of glycogen synthase kinase-3

1 reference

12 December 2020

No association of GSK3beta gene (GSK3B) with Japanese schizophrenia

1 reference

12 December 2020

GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.

1 reference

12 December 2020

Diverse psychotomimetics act through a common signaling pathway

1 reference

12 December 2020

Trimming, weighting, and grouping SNPs in human case-control association studies

1 reference

12 December 2020

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations

1 reference

12 December 2020

Searching for disease-susceptibility loci by testing for Hardy-Weinberg disequilibrium in a gene bank of affected individuals.

1 reference

12 December 2020

Implementing a unified approach to family-based tests of association.

1 reference

12 December 2020

A tutorial on statistical methods for population association studies

1 reference

12 December 2020

Power estimation of multiple SNP association test of case-control study and application

1 reference

12 December 2020

Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients

1 reference

12 December 2020

Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes

1 reference

12 December 2020

Pharmacogenetics of psychotropic drug response

1 reference

12 December 2020

10.1007/S00213-008-1193-9

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

18500637